Northwest Biotherapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $32.9M
Liabilities Breakdown FY2020
Total Liabilities: $395.8M
Asset Breakdown
Total Assets: $32.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $10.0M | 30.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.0M | 3.2% |
| Goodwill | $626.0K | 1.9% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $21.3M | 64.6% |
Liabilities Breakdown
Total Liabilities: $395.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $14.8M | 3.7% |
| Other Liabilities | $381.1M | 96.3% |